CH467861A - Verfahren zur Vermehrung von Staupeviren, welche zur Herstellung einer Vaccine zur Immunisierung von Musteliden gegen Staupe geeignet sind - Google Patents

Verfahren zur Vermehrung von Staupeviren, welche zur Herstellung einer Vaccine zur Immunisierung von Musteliden gegen Staupe geeignet sind

Info

Publication number
CH467861A
CH467861A CH56566A CH56566A CH467861A CH 467861 A CH467861 A CH 467861A CH 56566 A CH56566 A CH 56566A CH 56566 A CH56566 A CH 56566A CH 467861 A CH467861 A CH 467861A
Authority
CH
Switzerland
Prior art keywords
distemper
mustelids
immunization
vaccine
propagation
Prior art date
Application number
CH56566A
Other languages
German (de)
English (en)
Inventor
Ackermann Othmar
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of CH467861A publication Critical patent/CH467861A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175Canine distemper virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH56566A 1965-01-19 1966-01-07 Verfahren zur Vermehrung von Staupeviren, welche zur Herstellung einer Vaccine zur Immunisierung von Musteliden gegen Staupe geeignet sind CH467861A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB80160A DE1235505B (de) 1965-01-19 1965-01-19 Verfahren zur Herstellung einer Vaccine gegen Staupe

Publications (1)

Publication Number Publication Date
CH467861A true CH467861A (de) 1969-01-31

Family

ID=6980598

Family Applications (1)

Application Number Title Priority Date Filing Date
CH56566A CH467861A (de) 1965-01-19 1966-01-07 Verfahren zur Vermehrung von Staupeviren, welche zur Herstellung einer Vaccine zur Immunisierung von Musteliden gegen Staupe geeignet sind

Country Status (14)

Country Link
US (1) US3420934A (en])
AT (1) AT265517B (en])
BE (1) BE675341A (en])
CA (1) CA1002878A (en])
CH (1) CH467861A (en])
DE (1) DE1235505B (en])
DK (1) DK113460B (en])
FI (1) FI42460C (en])
FR (1) FR1587323A (en])
GB (1) GB1133958A (en])
LU (1) LU50203A1 (en])
NL (1) NL146881B (en])
NO (1) NO118229B (en])
SE (1) SE345688B (en])

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7504610L (sv) * 1974-04-25 1975-10-27 Inst Poliomielita I Virusnykh Forfarande for framstellning av en levande odlingsvirusvaccin mot pest hos kottetande djur.
DE2921040C2 (de) * 1979-05-23 1984-09-27 Moskovskij naučno-issledovatel'skij institut virusnych preparatov, Moskva Lebendimpfstoff zum Immunisieren von fleischfressenden Tieren gegen Staupe und Verfahren zu dessen Herstellung
US4554158A (en) * 1983-04-07 1985-11-19 Simonsen Laboratories, Inc. Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
WO2001047550A1 (en) * 1999-12-28 2001-07-05 Milkhaus Laboratory, Inc. Method for treatment of canine distemper

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1138888B (de) * 1959-09-03 1962-10-31 Behringwerke Ag Verfahren zur Herstellung einer Vaccine gegen Staupe
US3098011A (en) * 1959-09-03 1963-07-16 Behringwerke Ag Process of producing a vaccine against distemper
US3354038A (en) * 1964-12-02 1967-11-21 Affiliated Lab Corp Serial passaging tissue cultured canine distemper virus to form attenuated vaccine short of virus-antigenicity decreasing passages

Also Published As

Publication number Publication date
FI42460B (en]) 1970-04-30
NL6600639A (en]) 1966-07-20
BE675341A (en]) 1966-07-19
DK113460B (da) 1969-03-24
DE1235505B (de) 1967-03-02
GB1133958A (en) 1968-11-20
CA1002878A (en) 1977-01-04
SE345688B (en]) 1972-06-05
NL146881B (nl) 1975-08-15
US3420934A (en) 1969-01-07
FI42460C (fi) 1970-08-10
AT265517B (de) 1968-10-10
FR1587323A (en]) 1970-03-20
NO118229B (en]) 1969-12-01
LU50203A1 (en]) 1967-07-06

Similar Documents

Publication Publication Date Title
AT265642B (de) Verfahren zur Herstellung von wässerigen, emulgatorfreien Silicon-Emulsionen
CH487894A (de) Verfahren zur Herstellung von 1,2,3,4-Tetrahydro-9-aminoacridinen
AT271479B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
AT281311B (de) Verfahren zur Herstellung von 11β,17α-Dihydroxysteroiden
CH493519A (de) Verfahren zur Herstellung von 2,3-Pyridindiol
CH467861A (de) Verfahren zur Vermehrung von Staupeviren, welche zur Herstellung einer Vaccine zur Immunisierung von Musteliden gegen Staupe geeignet sind
CH485694A (de) Verfahren zur Herstellung von 4,7a-Dimethyl-4-androstenen
CH464188A (de) Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-6-halogen-9B,10 -steroiden
CH461499A (de) Verfahren zur Herstellung von 5H-Dibenzo-(b,f)-azepin
CH458336A (de) Verfahren zur Herstellung von 3-Keto- 4,5-6,6-spirocyclopropylsteroiden
AT272295B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH484277A (de) Verfahren zur Vermehrung von Masernviren, welche zur Herstellung einer Vaccine gegen Masern geeignet sind
CH482714A (de) Verfahren zur Herstellung von substituierten 1,3,4-Oxathiazol-2-onen
AT272294B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH508667A (de) Verfahren zur Herstellung von 2-Bisdiestern von Phosphonomethylamino-1,3-dihydroxypropan
AT259771B (de) Verfahren zur Herstellung von 6,7-Benzomorphanen
CH471072A (de) Verfahren zur Herstellung von 3,4-Dihydroxy-phenyl-alkanolaminen
CH461480A (de) Verfahren zur Herstellung von 6a, 9a-Difluor-16-methylen-1,4-pregnadien-3,20-dion-11B,17a-diol
CH451195A (de) Verfahren zur Herstellung von 2-Chlor-4H-1,3,2-dioxaphosphorin-4-one
CH480354A (de) Verfahren zur Herstellung von substituierten 1,3-Oxathiol-2-onen
CH481057A (de) Verfahren zur Herstellung von 1,3-Diaminoadamantanen
CH487170A (de) Verfahren zur Herstellung von 1,4-Diazacycloheptanen
CH483415A (de) Verfahren zur Herstellung von 3-Alkoxy-6-cyan-3,5-pregnadienen
CH467761A (de) Verfahren zur Herstellung von 1,2-Epoxy-9B,10a-steroiden
CH471832A (de) Verfahren zur Herstellung von 6B-Alkoxy-10B-carboxyl-3a,5-cyclosteroiden